Literature DB >> 3371611

Kinetics for the synthetic bile acid 75selenohomocholic acid-taurine in humans: comparison with [14C]taurocholate.

R P Jazrawi1, R Ferraris, C Bridges, T C Northfield.   

Abstract

The "apparent" fractional turnover rate of the gamma-labeled bile acid analogue 75selenohomocholic acid-taurine (75SeHCAT) was assessed from decline in radioactivity over the gallbladder area on 4 successive days using a gamma-camera, and was compared in the same subjects with the fractional turnover rate of the corresponding natural bile acid, cholic acid-taurine, labeled with 14C ([14C]CAT) using the classical Lindstedt technique. Very similar results were obtained in 5 healthy individuals (coefficient of variation 4.8%, medians 0.35 and 0.34, respectively). By contrast, the fractional deconjugation rate assessed from zonal scanning of glycine- and taurine-conjugated bile acids on thin-layer chromatography was much less for 75SeHCAT than for [14C]CAT (0.02 and 0.13, respectively; p less than 0.05). The fractional rate for deconjugation plus dehydroxylation was also determined by zonal scanning, and gave lower values for 75SeHCAT than for [14C]CAT (0.02 and 0.12, respectively; p less than 0.05). There was a striking similarity between the fractional rate for deconjugation alone and that for deconjugation plus dehydroxylation for both bile acids in individual samples (r = 0.999, p less than 0.001), suggesting that these two processes might occur simultaneously and probably involve the same bacteria. We conclude that our scintiscanning technique provides an accurate, noninvasive method of measuring fractional turnover rate of a bile acid in humans, and that the finding that 75SeHCAT remains conjugated with taurine during enterohepatic recycling means that absorption should be specific for the ileal active transport site, thus rendering it an ideal substance for assessing ileal function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371611     DOI: 10.1016/0016-5085(88)90306-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry.

Authors:  A F Hofmann
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

2.  [Increased bile acid retention in biliodigestive Roux-Y anastomosis in animal experiment].

Authors:  G Arlt; U Bolder; R Bares; V Schumpelick
Journal:  Langenbecks Arch Chir       Date:  1990

3.  Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).

Authors:  O Chazouillères; P Marteau; M Haniche; R Jian; R Poupon
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.

Authors:  A Lanzini; M G De Tavonatti; B Panarotto; S Scalia; A Mora; F Benini; O Baisini; F Lanzarotto
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

5.  Measurement of bile acid half-life using [75Se]HCAT in health and intestinal diseases. Comparison with [75Se]HCAT abdominal retention methods.

Authors:  R Ferraris; G Galatola; A Barlotta; R Pellerito; M Fracchia; F Cottino; M de la Pierre
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

6.  Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test.

Authors:  S Eusufzai; S Ericsson; T Cederlund; K Einarsson; B Angelin
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

7.  Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry.

Authors:  M Camilleri; A Nadeau; W J Tremaine; J Lamsam; D Burton; S Odunsi; S Sweetser; R Singh
Journal:  Neurogastroenterol Motil       Date:  2009-03-13       Impact factor: 3.598

8.  Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test.

Authors:  S Eusufzai; M Axelson; B Angelin; K Einarsson
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.